Dr. Martens PLC Will Buyback Up to £50 Million Worth of DOCS Shares 

• Dr Martens will repurchase up to £50 Million of shares.
• Sparta Capital accumulated £10 Million shares in Dr Martens.
• DOCS stock reaped 3.30% in the intraday session, and is now trading at £156.7.

The British footwear and clothing brand ”Dr. Martens” announced that it would repurchase up to £50 Million worth of DOCS shares to reduce its share capital. However, this program will be conducted in an agreement with Morgan Stanley & Co. Therefore, this program will possibly elevate growth in the DOCS stock, which will be witnessed throughout the market.

In early-2023, DOCS stock was moving in an uptrend and achieved an annual high but was halted there by the resistance level of £216.0. Furthermore, this accomplishment inspired the bears to move ahead, firing on all cylinders. Consequently, DOCS stock price observed a prompted downfall of about 33% and reached £144 in just three days.

Since then, DOCS stock has revealed several fluctuations and is now hovering near that £144 level. Throughout the year, DOCS stock price reached numerous high resistance levels, but from mid-April to end-May, the stock price has been stuck i an consolidation zone between £175.0 to £156. 

However, the bears liberated themselves from this zone, dragged the price downward to the £130 level, and subsequently, the price reached an annual low at the £113 support level. Since then, an uptrend momentum has been witnessed in the price action while forming higher lows.

Sparta Capital Accumulated £10 Million DOCS Stock

Furthermore, the latest uptrend was elevated when the Activist Fund Sparta Capital softly accumulated about £10 Million in Dr. Martens in late July 2023. This accumulation provided the needed growth in DOCS stock.

Recently, DOCS stock price has been hovering near £156 with a gain of 3.30% during the intraday session. If the current uptrend sustains in the market, the price might surge and retest the significant resistance level of £167. On the contrary, if bears manage to bring down the price, then the price might melt towards the crucial support level of £130.

Will The Uptrend Sustain?

DOCS stock is trading above the 20, 50, and 100-day EMAs, and if the uptrend remains consistent, the price will hopefully retest the 200-day EMA. However, the chaikin money flow (CMF) score is 0.02 during the intraday session, indicating slight strength and the possibility of a further hike.

The relative strength index (RSI) trades at 49.37, indicating neither strength nor weakness in the market, and hints that the price might consolidate. Additionally, the current market capitalization of Dr. Martens PLC is £1.65 Billion, with an average volume of 1.37 Million shares. 

Conclusion 

The current market scenario reflects bullish dominance in the market. However, Dr. Martens’s Stock surges ahead to gain new highs with an ongoing uptrend momentum. Investors should consider buying opportunities as the technical parameters reflect the same.  

Technical Levels

• Major resistance: £174.7 and £216.0
• Major support: £128.3 and £113.0

Disclaimer

The information provided in this article. Including the views and opinions expressed by the author or any individuals mentioned, is intended for informational purposes only. It is important to note that the article does not provide financial or investment advice. Investing or trading in cryptocurrency assets carries inherent risks and can result in financial loss.